Phreesia: Remain Buy Rated As The Business Pivot Towards Profitable Growth (NYSE:PHR)


Doctors working on the move



Following my coverage on Phreesia (NYSE:PHR), which I recommended a buy rating as I believe the valuation was attractive after the big share price dip. I thought that the business fundamentals remained sound, and if management were to


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *